VYGR - voyagertherapeutics.com Operating profit EBITDA

Graphic logo of Voyager Therapeutics Inc (VYGR)

Voyager Therapeutics (VYGR) is developing innovative CNS gene therapy methods in its US laboratories. The company's activities rely on a global humanitarian consensus, which eliminates the influence of political strife. However, dependence on foreign patents creates certain regulatory complexities. On GURU.Markets, the organization's total EBITDA demonstrates financial dynamics where the 0.00 indicator determines the status of the absolute operating profit parameter.

Voyager Therapeutics, Inc. (VYGR): Operating profit EBITDA from 11/23/2025 to 11/16/2026

Voyager Pharma - analytical breakdowns and key metrics (VYGR)

- market value and analyst target forecast:
Fundamental company valuation:Voyager Therapeutics VYGR
Brand item of Voyager Therapeutics Inc

Portfolio managers evaluate the operating model of Voyager Therapeutics (VYGR) based on the volume of actual cash inflows from core operations, which currently prices in the value of 0.00. By analyzing EBITDA volatility, investors can discern the effectiveness of the production and testing outsourcing strategy, which minimizes capital expenditures and confirms the company's financial stability during periods of market volatility.

Who Voyager Therapeutics competes with

Biogen Inc. (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|RGC (Regencell Bioscience Holdings Limited) - Operating profit before amortization|Axsome Corp (AXSM) - Profit before payment of interest, taxes and amortization|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|VKTX - Operating profit before depreciation charges|Operating profit before deduction of amortization SUPN (supernus.com)|Operating income before deduction of amortization Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Operating profit EBITDA|Operating profit before amortization CBLL (CeriBell Corp)|Profit before payment of interest, taxes and amortization Prothena Biosciences (PRTA)|Operating income before deduction of amortization Alector|Operating profit EBITDA ANNX (annexonbio.com)|Income before deduction of interest, taxes and amortization OMER|NGNE: Operating profit before deduction of amortization|ACIU (AC Immune Corp) - Operating profit before amortization|NMRA: Operating profit EBITDA|Scilex Holding Company - Income before deduction of interest, taxes and amortization|TVGN (Tevogen Bio Holdings, Inc.) - Operating profit EBITDA|Operating profit EBITDA Alpha Cognition|Operating profit EBITDA CGTX|IKT - Profit before interest, taxes and amortization|Operating profit EBITDA SAVA (cassavasciences.com)|Income before deduction of interest, taxes and amortization ASRT|Coya Therapeutics Inc - Operating profit EBITDA|Operating income before deduction of amortization vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals, Inc (ABOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CervoMed Inc.|Alterity Therapeutics (ATHE) - Operating income before deduction of amortization|Operating profit EBITDA CLNN|PEPG - Profit before interest, taxes and amortization|Operating profit EBITDA JUNS (Jupiter Neurosciences, Inc.)|RLMD - Operating profit before deduction of amortization|ANVS - Profit before payment of interest, taxes and amortization|Operating profit before depreciation charges Grace Therapeutics (GRCE)|AIFF: Operating profit EBITDA|ANEW Medical, Inc. (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd.|RVPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MTVA|Operating profit EBITDA NeurAxis (NRXS)|Helius Medical Technologies, Inc. - Operating profit before deduction of amortization|Operating income before deduction of amortization Passage Bio, Inc. (PASG)|Neuphoria - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NERV (Minerva)|ATHA: Operating profit EBITDA|Operating profit before amortization ADXN|Operating profit before deduction of amortization ALZN|Profit before interest, taxes and amortization Cyclerion Therapeutics CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Operating profit EBITDA Pasithea Therapeutics Corp (KTTA)|Cortigent, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Avenue Therapeutics ATXI|BCLI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CARA (Cara Therapeutics)|Chromocell Therapeutics Corporation (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics, Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|Profit before interest, taxes and amortization longboardpharma.com LBPH|Profit before payment of interest, taxes and amortization Marinus (MRNS)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo)|Income before deduction of interest, taxes and amortization SAGE|SNPX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Trevena|VIGL: Operating profit EBITDA|WENA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel